钙磷涂层的JDBM镁合金多孔支架促进血管新生及骨缺损修复的效果评估

doi:10.3969/j.issn.1674-8115.2021.06.005

摘要/Abstract

摘要：

目的·研究含有钙磷涂层（CaHPO₄·2H₂O，DCPD）的JDBM（Mg-Nd-Zn-Zr）镁合金支架体内外促血管新生和骨缺损修复的生物学效应。方法·应用模板复制法和化学沉积法构建JDBM-DCPD和JDBM-MgF₂支架，使用微型CT（micro-CT）和扫描电子显微镜检测2种支架的表征。在支架表面种植骨髓间充质干细胞（bone marrow mesenchymal stem cell， BMSC）并通过CCK-8实验及细胞黏附实验观察支架对细胞的生物相容性。通过Transwell细胞迁移实验和成管实验检测支架浸提液对内皮细胞系Ea.hy926细胞迁移和成管能力的影响，并通过免疫荧光染色进一步观察血管内皮生长因子（vascular endothelial growth factor，VEGF）的分泌情况；通过碱性磷酸酶和茜素红染色检测浸提液对BMSC成骨能力的影响。构建SD大鼠股骨髁临界性骨缺损模型并植入支架，术后8周通过Microfil血管灌注、micro-CT扫描、组织切片染色等方法评估JDBM-DCPD支架的促血管新生及促成骨能力。结果·JDBM-DCPD支架的主孔径为400~450 μm，钙磷颗粒均匀分布在孔壁上，大小为15~25 μm。BMSC能够在JDBM-DCPD支架表面黏附且生长良好。与对照组和JDBM-MgF₂支架浸提液相比，JDBM-DCPD支架浸提液在体外能够显著促进Ea.hy926内皮细胞迁移、成管以及VEGF的表达，同时可显著增强BMSC早期和晚期成骨分化。体内植入8周后，JDBM-DCPD支架促进缺损区血管和新骨再生作用显著优于JDBM-MgF₂支架。结论·JDBM-DCPD支架在体内外实验中展现了优良的成血管效应，特别是在体内植入后可以实现早期血管化，从而更加有效地促进骨再生。

关键词: Mg-Nd-Zn-Zr合金, DCPD涂层, 血管新生, 成骨分化, 骨再生, 骨组织工程

Abstract:

Objective·To evaluate the biological effects of JDBM (Mg-Nd-Zn-Zr) scaffold coated with DCPD (CaHPO₄·2H₂O) on angiogenesis and repairing bone defects in vivo and in vitro.

Methods·The JDBM-DCPD and JDBM-MgF₂ scaffolds were constructed by using template replication method and chemical deposition method, and the characteristics of the scaffolds were observed by micro-CT and scan electron microscope. The bone marrow mesenchymal stem cells (BMSCs) were seeded on the scaffolds and the biocompatibility of scaffolds was evaluated by CCK-8 experiment and cell adhesion experiment. Transwell cell migration experiment and tube formation experiment were used to detect the effects of scaffold extracts on the migration and tube-forming ability of endothelial cell line Ea.hy926 cells, and immunofluorescence was used to further observe the secretion of vascular endothelial growth factor (VEGF). Alkaline phosphatase staining and alizarin red staining were used to detect the effect of the extracts on the osteogenic ability of BMSCs. Furthermore, the model of critical bone defect of femoral condyle was constructed in SD rats. The JDBM-DCPD and JDBM-MgF₂ scaffolds were implanted into the defects, respectively, and the effects of scaffolds on the osteogenesis and vascularization were assessed by Microfil vascular perfusion, micro-CT scanning, and tissue section staining after 8 weeks of operation.

Results·The main spherical pore size of JDBM-DCPD scaffold was 400?450 μm and the calcium and phosphorus particles were evenly distributed on the pore wall with the size of 15?25 μm. BMSCs adhered and grew well on the surface of JDBM-DCPD scaffold. Compared with the control group and the JDBM-MgF₂ scaffold extract, the JDBM-DCPD scaffold extract could significantly promote the migration, tube formation and VEGF expression of Ea.hy926 cells, and significantly enhance the early and late osteogenic differentiation of BMSCs in vitro. After 8 weeks of implantation, the JDBM-DCPD scaffold dramatically facilitated the regeneration of new bone and new vessels in the defect area compared with the JDBM-MgF₂ scaffold.

Conclusion·The JDBM-DCPD scaffold exhibits excellent vascularization effects both in vivo and in vitro, especially early vascularization effect after implantation and bone regeneration promotion in vivo.

Key words: Mg-Nd-Zn-Zr alloy (JDBM), DCPD coat, angiogenesis, osteogenic differentiation, bone regeneration, bone tissue engineering

中图分类号:

R318.08

王青, 王伟, 姜达君, 贾伟涛. 钙磷涂层的JDBM镁合金多孔支架促进血管新生及骨缺损修复的效果评估[J]. 上海交通大学学报(医学版), 2021, 41(6): 732-740.

Qing WANG, Wei WANG, Da-jun JIANG, Wei-tao JIA. Evaluation of JDBM porous scaffold coated with DCPD in promoting angiogenesis and repairing bone defects[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(6): 732-740.

图/表 7

图1 JDBM-DCPD与JDBM支架表征的比较Note: A. 3D reconstruction images of JDBM-MgF2 and JDBM-DCPD porous scaffolds. B. SEM to observe the pore size and surface structure of the scaffolds (above ×100, below ×5 000). C. The porosities of JDBM-MgF2 and JDBM-DCPD porous scaffolds. ① P=0.000， compared with the JDBM-MgF2 group.

Fig 1 Comparison of JDBM-DCPD and JDBM-MgF2 porous scaffolds in characteristics

图2 JDBM-DCPD与JDBM-MgF2支架生物相容性的比较Note: A. Cell proliferation activity of BMSCs cultured on the scaffolds for 7 d detected by CCK8 kit. ①P=0.000, compared with the JDBM-MgF2 group. B. Cell adhesion of BMSCs cultured on the scaffolds for 7 d observed by SEM (above ×250, below ×1 000).

Fig 2 Comparison of JDBM-DCPD and JDBM-MgF2 in biocompatibility

图3 JDBM-DCPD与JDBM-MgF2支架浸提液对Ea.hy926细胞迁移能力和成管情况影响的比较Note: A. Representative photographs showing the effect of the extracts of JDBM-DCPD and JDBM-MgF2 on the migration of Ea.hy926 cells after incubation for 24 h detected by Transwell migration assay (crystal violet staining, ×100). B. Quantitation of migrating Ea.hy926 cells. C. Representative photographs showing the effect of the extracts of JDBM-DCPD and JDBM-MgF2 on the tubule formation of Ea.hy926 cells after incubation for 3 h and 6 h (×100). D. Quantitation of tubule formation of Ea.hy926 cells. ①P=0.000, compared with the control group; ②P=0.007, ③P=0.000, compared with the JDBM-MgF2 group. HPF—high power field.

Fig 3 Comparison of the effects of JDBM-DCPD and JDBM-MgF2 scaffold extracts on Ea.hy926 cell migration and tube formation

图4 JDBM-DCPD与JDBM-MgF2支架浸提液对Ea.hy926细胞VEGF表达水平影响的比较Note:A. Representative photographs showing the effect of the extracts of JDBM-DCPD and JDBM-MgF2 on the expression of VEGF in Ea.hy926 cells after incubation for 3 d detected by immunofluorescent (×200). B. Semi-quantitative analysis of fluorescence intensity. ①P=0.001, ②P=0.000, compared with the control group; ③P=0.004, compared with the JDBM-MgF2 group.

Fig 4 Comparison of the effects of JDBM-DCPD and JDBM-MgF2 scaffold extracts on the expression of VEGF in Ea.hy926 cells

图5 JDBM-DCPD与JDBM-MgF2支架浸提液对BMSC成骨分化影响的比较Note:A. ALP staining of BMSCs cultured in the scaffold extracts for 7 d and 14 d, respectively (×100). B. ARS staining of BMSCs cultured in the scaffold extracts for 14 d (×100).

Fig 5 Comparison of effects of JDBM-DCPD and JDBM-MgF2 scaffold extracts on osteogenic differentiation of BMSCs

图6 植入8周后影像学检测JDBM-DCPD与JDBM-MgF2支架的体内成骨、成血管作用Note: A. X-ray photos. B. Three-dimensional reconstruction and sagittal images by CT. C. Microfil perfusion to observe the formation of new blood vessels in the defect area. The white circles indicate the bone defect area.

Fig 6 Osteogenesis and angiogenesis of JDBM-DCPD and JDBM-MgF2 scaffolds in vivo detected by radiography 8 weeks after implantation

图7 植入8周后JDBM-DCPD组与JDBM-MgF2组大鼠骨缺损区的组织学观察Note:A. H-E staining of the bone defect areas (above×200, below×400). B. Expression of OCN in the defect areas (immunohistochemical staining, ×400). C. Expression of CD31 in the defect areas (immunohistochemical staining, ×400). The white arrows represent the new bone tissues and the red arrows represent the new blood vessels.

Fig 7 Histological observation of the bone defect areas in JDBM-DCPD group and JDBM-MgF2 group rats 8 weeks after implantation

参考文献 41

1	Giannoudis PV, Dinopoulos H, Tsiridis E. Bone substitutes: an update[J]. Injury, 2005, 36(): S20-S27.
2	Moore WR, Graves SE, Bain GI. Synthetic bone graft substitutes[J]. ANZ J Surg, 2001, 71(6): 354-361.
3	Samartzis D, Shen FH, Goldberg EJ, et al. Is autograft the gold standard in achieving radiographic fusion in one-level anterior cervical discectomy and fusion with rigid anterior plate fixation?[J]. Spine, 2005, 30(15): 1756-1761.
4	Jin L, Li P, Wang YC, et al. Studies of superb microvascular imaging and contrast-enhanced ultrasonography in the evaluation of vascularization in early bone regeneration[J]. J Ultrasound Med, 2019, 38(11): 2963-2971.
5	Brandi ML, Collin-Osdoby P. Vascular biology and the skeleton[J]. J Bone Miner Res, 2006, 21(2): 183-192.
6	Parfitt AM. The mechanism of coupling: a role for the vasculature[J]. Bone, 2000, 26(4): 319-323.
7	Novosel EC, Kleinhans C, Kluger PJ. Vascularization is the key challenge in tissue engineering[J]. Adv Drug Deliv Rev, 2011, 63(4/5): 300-311.
8	Rouwkema J, Rivron NC, van Blitterswijk CA. Vascularization in tissue engineering[J]. Trends Biotechnol, 2008, 26(8): 434-441.
9	Kanczler JM, Oreffo RO. Osteogenesis and angiogenesis: the potential for engineering bone[J]. Eur Cell Mater, 2008, 15: 100-114.
10	Thevenot P, Nair A, Dey J, et al. Method to analyze three-dimensional cell distribution and infiltration in degradable scaffolds[J]. Tissue Eng Part C Methods, 2008, 14(4): 319-331.
11	Staiger MP, Pietak AM, Huadmai J, et al. Magnesium and its alloys as orthopedic biomaterials: a review[J]. Biomaterials, 2006, 27(9): 1728-1734.
12	Velasco MA, Narváez-Tovar CA, Garzón-Alvarado DA. Design, materials, and mechanobiology of biodegradable scaffolds for bone tissue engineering[J]. Biomed Res Int, 2015, 2015: 729076.
13	Kunjukunju S, Roy A, Ramanathan M, et al. A layer-by-layer approach to natural polymer-derived bioactive coatings on magnesium alloys[J]. Acta Biomater, 2013, 9(10): 8690-8703.
14	Zhang J, Ma X, Lin D, et al. Magnesium modification of a calcium phosphate cement alters bone marrow stromal cell behavior via an integrin-mediated mechanism[J]. Biomaterials, 2015, 53: 251-264.
15	Qin H, Zhao Y, An Z, et al. Enhanced antibacterial properties, biocompatibility, and corrosion resistance of degradable Mg-Nd-Zn-Zr alloy[J]. Biomaterials, 2015, 53: 211-220.
16	Kong X, Wang L, Li G, et al. Mg-based bone implants show promising osteoinductivity and controllable degradation: a long-term study in a goat femoral condyle fracture model[J]. Mater Sci Eng C Mater Biol Appl, 2018, 86: 42-47.
17	Guan X, Xiong M, Zeng F, et al. Enhancement of osteogenesis and biodegradation control by brushite coating on Mg-Nd-Zn-Zr alloy for mandibular bone repair[J]. ACS Appl Mater Interfaces, 2014, 6(23): 21525-21533.
18	Tamimi F, Sheikh Z, Barralet J. Dicalcium phosphate cements: brushite and monetite[J]. Acta Biomater, 2012, 8(2): 474-487.
19	Apelt D, Theiss F, El-Warrak AO, et al. In vivo behavior of three different injectable hydraulic calcium phosphate cements[J]. Biomaterials, 2004, 25(7): 1439-1451.
20	Malhotra A, Habibovic P. Calcium phosphates and angiogenesis: implications and advances for bone regeneration[J]. Trends Biotechnol, 2016, 34(12): 983-992.
21	Wang W, Jia G, Wang Q, et al. The in vitro and in vivo biological effects and osteogenic activity of novel biodegradable porous Mg alloy scaffolds[J]. Mater Des, 2020, 189: 108514.
22	Pijuan J, Barceló C, Moreno DF, et al. In vitro cell migration, invasion, and adhesion assays: from cell imaging to data analysis[J]. Front Cell Dev Biol, 2019, 7: 107.
23	Hu H, Chen Y, Zou Z, et al. Panax notoginseng saponins prevent bone loss by promoting angiogenesis in an osteoporotic mouse model[J]. Biomed Res Int, 2020, 2020: 8412468.
24	Dai C, Guo H, Lu J, et al. Osteogenic evaluation of calcium/magnesium-doped mesoporous silica scaffold with incorporation of rhBMP-2 by synchrotron radiation-based μCT[J]. Biomaterials, 2011, 32(33): 8506-8517.
25	Griffith LG. Emerging design principles in biomaterials and scaffolds for tissue engineering[J]. Ann N Y Acad Sci, 2002, 961: 83-95.
26	Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis[J]. Biomaterials, 2005, 26(27): 5474-5491.
27	Chiesa R, Sandrini E, Santin M, et al. Osteointegration of titanium and its alloys by anodic spark deposition and other electrochemical techniques: a review[J]. J Appl Biomater Biomech, 2003, 1(2): 91-107.
28	Liang C, Wang H, Yang J, et al. Femtosecond laser-induced micropattern and Ca/P deposition on Ti implant surface and its acceleration on early osseointegration[J]. ACS Appl Mater Interfaces, 2013, 5(16): 8179-8186.
29	Ma H, Luo J, Sun Z, et al. 3D printing of biomaterials with mussel-inspired nanostructures for tumor therapy and tissue regeneration[J]. Biomaterials, 2016, 111: 138-148.
30	Xu F, Ding H, Song F, et al. Effects of preparation methods on the bone formation potential of apatite-coated chitosan microspheres[J]. J Biomater Sci Polym Ed, 2014, 25(18): 2080-2093.
31	Yu W, Zhao H, Ding Z, et al. In vitro and in vivo evaluation of MgF₂ coated AZ31 magnesium alloy porous scaffolds for bone regeneration[J]. Colloids Surf B Biointerfaces, 2017, 149: 330-340.
32	Lafage-Proust MH, Prisby R, Roche B, et al. Bone vascularization and remodeling[J]. Joint Bone Spine, 2010, 77(6): 521-524.
33	Kusumbe AP, Ramasamy SK, Adams RH. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone[J]. Nature, 2014, 507(7492): 323-328.
34	Dhandapani R, Krishnan PD, Zennifer A, et al. Additive manufacturing of biodegradable porous orthopaedic screw[J]. Bioact Mater, 2020, 5(3): 458-467.
35	Xie H, Cui Z, Wang L, et al. PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis[J]. Nat Med, 2014, 20(11): 1270-1278.
36	Liu Q, Zhou YF, Li ZB. PDGF‑BB promotes the differentiation and proliferation of MC3T3‑E1 cells through the Src/JAK2 signaling pathway[J]. Mol Med Rep, 2018, 18(4): 3719-3726.
37	Liu W, Guo S, Tang Z, et al. Magnesium promotes bone formation and angiogenesis by enhancing MC3T3-E1 secretion of PDGF-BB[J]. Biochem Biophys Res Commun, 2020, 528(4): 664-670.
38	Saghiri MA, Asatourian A, Orangi J, et al. Functional role of inorganic trace elements in angiogenesis—part Ⅰ: N, Fe, Se, P, Au, and Ca[J]. Crit Rev Oncol Hematol, 2015, 96(1): 129-142.
39	Song GL, Song SZ. A possible biodegradable magnesium implant material[J]. Adv Eng Mater, 2007, 9(4): 298-302.
40	Gu XN, Zheng YF, Chen LJ. Influence of artificial biological fluid composition on the biocorrosion of potential orthopedic Mg-Ca, Az31, Az91 alloys[J]. Biomed Mater, 2009, 4(6): 065011.
41	Fischer J, Prosenc MH, Wolff M, et al. Interference of magnesium corrosion with tetrazolium-based cytotoxicity assays[J]. Acta Biomater, 2010, 6(5): 1813-1823.

[1]	陆艳青, 周兴, 李姣, 彭建平, 王传东, 张晓玲. 抗肿瘤药物依托泊苷促进间充质干细胞成骨分化的研究[J]. 上海交通大学学报(医学版), 2021, 41(7): 849-857.
[2]	汤静, 于晨溪, 陈中丽, 章安迪. CTRP2与冠状动脉阻塞患者侧支循环形成的临床关联及相关作用[J]. 上海交通大学学报(医学版), 2021, 41(7): 915-919.
[3]	陈帅1，丁风华2，代杨1，陆林2，沈迎2，沈卫峰2. 炎症细胞参与侧支循环形成的研究进展[J]. 上海交通大学学报（医学版）, 2020, 40(3): 380-.
[4]	崔雅琦，白玉冰，许怡晨，谭心辰，李梦莹，贾浩. 脂肪来源的间充质干细胞及外囊泡促成骨分化的研究进展[J]. 上海交通大学学报(医学版), 2020, 40(12): 1672-1676.
[5]	李元，史俊宇，张枭，赖红昌. 上颌前牙区牙槽骨缺损形态学特征与引导骨再生手术效果的相关性研究[J]. 上海交通大学学报(医学版), 2020, 40(10): 1414-1419.
[6]	宁航，夏一如，董家辰，束蓉. 载重组人釉原蛋白水凝胶缓释系统对人牙周膜成纤维细胞生物学特性的影响[J]. 上海交通大学学报（医学版）, 2019, 39(3): 244-.
[7]	李晖，张术涛，岳冰. 小分子抗菌肽 KR -12-a5促进人骨髓间充质干细胞成骨分化的作用[J]. 上海交通大学学报（医学版）, 2018, 38(8): 881-.
[8]	程若昱，燕宇飞，陈皓，齐进，邓廉夫，崔文国. 双效骨诱导性的有机 - 无机水凝胶的构建及其骨再生研究[J]. 上海交通大学学报（医学版）, 2018, 38(8): 900-.
[9]	陈明姣，范先群. 透明质酸-明胶双网络水凝胶促进骨髓间充质干细胞成骨分化的作用[J]. 上海交通大学学报（医学版）, 2018, 38(7): 722-.
[10]	陈晓婷，高艳虹. 间充质干细胞成骨分化中多种调控因子的交互作用及其机制[J]. 上海交通大学学报（医学版）, 2017, 37(05): 694-.
[11]	贾朗，黄荣忠，王愉乐，贾功伟. 不同强度体外冲击波联合骨髓间充质干细胞移植对大鼠骨缺损的修复效果[J]. 上海交通大学学报（医学版）, 2016, 36(12): 1706-.
[12]	余章,黄雅琢,杨潇璇,肖彩雯. miR-424在人脂肪来源间充质干细胞成骨分化中的调控作用[J]. 上海交通大学学报（医学版）, 2016, 36(07): 962-.
[13]	常清璇,杨沛瑯,刘琰，等. 局部应用胰岛素调控基质金属蛋白酶对糖尿病创面血管新生的影响[J]. 上海交通大学学报（医学版）, 2015, 35(9): 1258-.
[14]	胡斌，陈春媛，汪泱，等. Neogenin调控成骨分化机制的研究进展[J]. 上海交通大学学报（医学版）, 2014, 34(5): 746-.
[15]	刘鹃，汪泱，沈晓黎，等. 长链非编码RNAs及其调控血管新生的研究进展[J]. 上海交通大学学报（医学版）, 2013, 33(9): 1301-.